MAP Online

MAP Online is a comprehensive Market Access resource. It details all the processes, policies and stakeholders you need to know to plan your Market Access journey. Validated by experts, updated regularly and constantly improving with insights from our consultancy team it has helped over 450 clients since it was created in 2012.

MAP Online Germany

MAP Online, Germany

Germany is one of the most attractive EU markets for pharmaceuticals. Pharmaceutical companies can freely determine the initial reimbursement price of their drug through the AMNOG procedures. AMNOG lays out the process for pricing and reimbursement of a new drug, following initial assessment by the Federal Joint Committee (G-BA), then pricing negotiation between the National Association of Statutory Health Insurance Funds (GKV-SV) and the marketing authorisation holder.

MAP Online Germany has a wealth of resources to support you when navigating the AMNOG process through to successful launch in Germany, including sections on:

  •  HTA report development and structure

  •  The process for reimbursement and dossier requirements

  •  Strategy for ATMPs, orphan medicines and vaccines

MAP OnlineMAP Online Germany

MAP Online
Germany

Germany is one of the most attractive EU markets for pharmaceuticals. Pharmaceutical companies can freely determine the initial reimbursement price of their drug through the AMNOG procedures. AMNOG lays out the process for pricing and reimbursement of a new drug, following initial assessment by the Federal Joint Committee (G-BA), then pricing negotiation between the National Association of Statutory Health Insurance Funds (GKV-SV) and the marketing authorisation holder.

MAP Online Germany has a wealth of resources to support you when navigating the AMNOG process through to successful launch in Germany, including sections on:

  •  HTA report development and structure

  •  The process for reimbursement and dossier requirements

  •  Strategy for ATMPs, orphan medicines and vaccines

Your MAP Online membership will give you access to:

  •  Expert Market Access support

  •  Essential Market Access resources

  •  Downloadable free tools

  •  The latest Market Access News

  •  Free ticket to the MAP Patient Access Conference

  •  10% consultancy discount

Benefits of MAP Online

  •  Save time

  •  Maximise efficiency

  •  Avoid common mistakes

  •  Effectively implement public affairs strategies

  •  Save money

CareersTerms and ConditionsComplaints ProcedurePrivacy PolicyCookie Policy

Copyright © 2021.
MAP BioPharma Limited.
All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

 +44 (0) 1480 832360

 enquiries@mapbiopharma.com

MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281

VAT Group Registration Number:
GB 292 8576 52